Dysfunctional Uterine Bleeding During Adolescence

In: ISGE Series · 2014 · pp. 9–14 · doi:10.1007/978-3-319-03494-2_2 · W1507660111
book-chapter OA: closed CC0 ⤵ 1 in-corpus citation
Full text JSON View on OpenAlex View at publisher
AI-generated summary by claude@2026-06+body, 2026-06-07

Dysfunctional uterine bleeding, often occurring in adolescence due to immature hypothalamic-pituitary-ovarian axis, presents as painless, excessive, or irregular bleeding managed through history, examination, and various tests.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text

The paper reviews dysfunctional uterine bleeding (DUB) during adolescence, describing its definition as abnormal, often painless, excessive and irregular endometrial bleeding without an organic cause, and attributing most cases to delayed maturation of the hypothalamic–pituitary–ovarian axis. It outlines high-level evaluation steps including detailed history and gynecologic examination (even in virginal patients), targeted laboratory tests, pelvic ultrasonography and further imaging when needed, with endocrinologic testing not always required. The key claims are that about 95% of adolescent DUB reflects late maturation of this axis, and that severity-based management is typically guided by hormonal stabilization strategies (e.g., combined oral contraceptives for mild cases and estradiol or cyclic progestogens for moderate/severe categories). This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 5,356 characters · extracted from oa-doi-fallback · 3 sections · click to expand

Abstract

Dysfunctional uttering bleeding (DUB) is an abnormal uterine bleeding in the absence of organic cause. It is usually a painless, excessive and irregular endometrial bleeding that may be prolonged, and it is not attributable to any underlying structural or systemic disease. The etiology DUB arises out of continuing maturation of the hypothalamus, such that the eventual establishment of normal pulsatile gonadotropin release leads to normal menstrual cycle control. DUB is usually seen during adolescence. In about 95% of cases DUB is due to the late maturation of the hypothalamic–pituitary–ovarian axis. The evaluation of DUB cases includes a detailed family and personal history as well as a careful gynecological examination, including visualization of the cervix, even in virgin young girls (vaginoscopy), laboratory studies: hematocrit, hemospherin, and others, pelvic ultrasonography, radiological imaging procedures, and rarely hysteroscopy or/and curretage. Endocrinological tests are not always necessary. The disease is classified as mild, moderate, or severe. In mild DUB cases the use of combined oral contraceptives is occasionally indicated as well as a careful follow-up. In cases of moderate degree the use of the new generation 17β-estradiol or the cyclic use of progestagenic compounds is the treatment of choice. Cyclic oral progestogens are administered for the same 10 days every month to prevent the action of unopposed estrogens and stabilize the endometrium. Access this chapter Tax calculation will be finalised at checkout Purchases are for personal use only Similar content being viewed by others

References

Deligeoroglou E, Tsimaris P (2010) Menstrual disturbances in puberty. Best Pract Res Clin Obstet Gynaecol 24(2):157–171 Fraser IS, Sungurtekin U (2000) Defining menstrual disturbances. In: Maclean A, O’Brien PMS (eds) Study group on menstrual disorders. Royal College of Obstetricians and Gynecologist, London, pp 141–152 Deligeoroglou E, Karountzos V, Creatsas G (2013) Abnormal uterine bleeding and dysfunctional uterine bleeding in pediatric and adolescent gynecology. Gynecol Endocrinol 29(1):74–78 Ferenczy A (2003) Pathophysiology of endometrial bleeding. Maturitas 45(1):1–14 Talib HJ, Coupey SM (2012) Excessive uterine bleeding. Adolesc Med State Art Rev 23(1):53–72 Deligeoroglou E (1997) Dysfunctional uterine bleeding. Ann N Y Acad Sci 816:158–164 Deligeoroglou E, Tsimaris P, Deliveliotou A, Christopoulos P, Creatsas G (2006) Menstrual disorders during adolescence. Pediatr Endocrinol Rev 3(Suppl 1):150–159 Claessens EA, Cowell CA (1981) Acute adolescent menorrhagia. Am J Obstet Gynecol 139(3):277–280 Deligeoroglou E, Creatsas G (2012) Menstrual disorders. Endocr Dev 22:160–170 Reynolds LL, Birkimer JC (2002) Perceptions of child sexual abuse: victim and perpetrator characteristics, treatment efficacy, and lay vs. legal opinions of abuse. J Child Sex Abus 11(1):53–74 Mammen EF (2000) In: Beutler E (ed) Williams hematology, 6th edn. McGraw-Hill Professional, New York, NY, p 1673 Minjarez DA, Bradshaw KD (2000) Abnormal uterine bleeding in adolescents. Obstet Gynecol Clin North Am 27(1):63–78 Kouides PA (2001) Obstetric and gynaecological aspects of von Willebrand disease. Best Pract Res Clin Haematol 14(2):381–399 Bevan JA, Maloney KW, Hillern CA et al (2001) Bleeding disorders. A common cause of menorrhagia in adolescents. J Pediatr 138:856–861 Kadir RA, Aledort LM (2000) Obstetrical and gynaecological bleeding. A common presenting symptom. Clin Lab Haematol 22(Suppl 1):12–16 Creatsas G (1998) Tenoxicam versus Lyn-EE treatment of DUB during adolescence. J Pediatr Adolesc Gynecol 11(4):177–180 Edlund M, Andersson K, Rybo G (1995) Reduction of menstrual blood loss in women suffering from idiopathic menorrhagia with a novel antifibrinolytic drug (Kabi 2161). Br J Obstet Gynaecol 102(11):913–917 Sokkary N, Dietrich JE (2012) Management of heavy menstrual bleeding in adolescents. Curr Opin Obstet Gynecol 24(5):275–280 Hickey M, Higham JM, Fraser I (2012) Progestogens with or without oestrogen for irregular uterine bleeding associated with anovulation. Cochrane Database Syst Rev 9, CD001895. pub3, doi: 10.1002/14651858 Olive DL (2002) Role of progesterone antagonists and new selective progesterone receptor modulators in reproductive health. Obstet Gynecol Surv 57(11 Suppl 4):S55–S63 Author information Authors and Affiliations Corresponding author Editor information Editors and Affiliations Rights and permissions Copyright information © 2014 Springer International Publishing Switzerland About this chapter Cite this chapter Creatsas, M., Creatsas, G.K. (2014). Dysfunctional Uterine Bleeding During Adolescence. In: Genazzani, A.R., Brincat, M. (eds) Frontiers in Gynecological Endocrinology. ISGE Series. Springer, Cham. https://doi.org/10.1007/978-3-319-03494-2_2 Download citation DOI: https://doi.org/10.1007/978-3-319-03494-2_2 Publisher Name: Springer, Cham Print ISBN: 978-3-319-03493-5 Online ISBN: 978-3-319-03494-2 eBook Packages: MedicineMedicine (R0)

Keywords

- Luteinizing Hormone - Immune Thrombocytopenic Purpura - Endometrial Thickness - Premature Ovarian Failure - Endometrial Hyperplasia These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

Cited by (1)

References (19)

Cited by (1)

Source provenance

openalex
last seen: 2026-05-11T04:39:21.785218+00:00
License: CC0 · commercial use OK